Background: Multiple treatment options at glioblastoma progression exist, including reintervention, reirradiation, additional systemic therapy, and novel strategies. No alternative has been proven to be superior in terms of postprogression survival (PPS). A second surgery has shown conflicting evidence in the literature regarding its prognostic impact, possibly affected by selection bias, and might benefit a sparse subset of patients with recurrent glioblastoma.
View Article and Find Full Text PDFIn this work, the characterization of the species produced in reactive plasmas by differentially pumped mass spectrometry is addressed. A H2/CH4/N2 mixture (90 : 5 : 5) was fed into a direct current glow discharge and analysed by conventional and cryo-trap assisted mass spectrometry. The gaseous mixture was chosen because of its particular relevance in the inhibition of tritium-rich carbon film deposition in fusion plasmas (scavenger technique) and in the deposition of amorphous hydrogenated carbon films by plasma-assisted chemical vapour deposition.
View Article and Find Full Text PDF